Mohamed F Alajmi Selected Research

Mohamed F Alajmi Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 08/2018
3	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 02/2014
3	Infections 02/2021 - 08/2018
3	Neoplasm Metastasis (Metastasis) 02/2020 - 01/2019
2	COVID-19 01/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2019 - 12/2017
1	Nematode Infections 04/2024
1	Malaria 11/2023
1	Rheumatoid Arthritis 01/2022
1	Obesity 01/2022
1	Atherosclerosis 01/2022
1	Multiple Sclerosis 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 03/2021
1	Cerebroretinal Microangiopathy with Calcifications and Cysts 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Cutaneous Malignant Melanoma 03/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Genomic Instability 01/2020
1	Thrombosis (Thrombus) 10/2019
1	Neuroblastoma 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Edema (Dropsy) 02/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2023 - 06/2019
6	sphingosine kinaseIBA 01/2022 - 10/2019
5	Phosphotransferases (Kinase)IBA 01/2024 - 02/2019
3	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2024 - 07/2019
2	Antimalarials (Antimalarial Agents)IBA 11/2023 - 01/2021
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2020
2	EnzymesIBA 01/2022 - 10/2019
2	Pyruvic Acid (Pyruvate)IBA 02/2021 - 07/2019
2	Rivastigmine (Exelon)FDA LinkGeneric 04/2020 - 01/2020
2	tartaric acid (tartrate)FDA Link 04/2020 - 01/2020
1	AnionsIBA 04/2024
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 04/2024
1	Superoxides (Superoxide)IBA 04/2024
1	Rutin (Rutoside)IBA 03/2024
1	ThymolIBA 01/2024
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2023
1	HexokinaseIBA 01/2022
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Phosphates (Orthophosphate)IBA 04/2021
1	SphingosineIBA 04/2021
1	Peptide Hydrolases (Proteases)FDA Link 02/2021
1	Multifunctional EnzymesIBA 02/2021
1	CarcinogensIBA 01/2021
1	remdesivirIBA 01/2021
1	umifenovirIBA 01/2021
1	Lopinavir FDA Link 01/2021
1	vanillinIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Cyclin-Dependent Kinase 6IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	favipiravirIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Plant ExtractsIBA 01/2021
1	VitaminsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Serum AlbuminIBA 04/2020
1	DNA (Deoxyribonucleic Acid)IBA 03/2020
1	Mutant Proteins (Protein, Mutant)IBA 03/2020
1	Hormones (Hormone)IBA 02/2020
1	OligonucleotidesIBA 01/2020
1	ferulic acid (sodium ferulate)IBA 01/2020
1	Carbonic Anhydrase IXIBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Rosmarinic AcidIBA 01/2020
1	AcidsIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	IronIBA 01/2020
1	OligosaccharidesIBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	QuercetinIBA 12/2019
1	Capsaicin (Zostrix)FDA Link 12/2019
1	Glycoproteins (Glycoprotein)IBA 10/2019
1	SphingolipidsIBA 10/2019
1	von Willebrand FactorIBA 10/2019
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 07/2019
1	TriazolesIBA 02/2019
1	Carotenoids (Carotene)IBA 02/2019
1	HydrazonesIBA 02/2019
1	AntioxidantsIBA 02/2019
1	IsatinIBA 02/2019
1	Linoleic Acid (Linoleate)IBA 02/2019
1	HesperidinIBA 01/2019
1	SilverIBA 01/2019
1	Anti-Infective Agents (Microbicides)IBA 08/2018
1	ethyl N-alpha-acetyl-tyrosinate (ATEE)IBA 12/2017
1	Methylene Chloride (Dichloromethane)IBA 02/2014
1	Formaldehyde (Formol)FDA Link 02/2014

Therapy/Procedure

13	Therapeutics 03/2024 - 06/2019
1	Precision Medicine 01/2021